The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins
Related Experiment Video
Updated: Apr 26, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Fellype Carvalho Barreto1, Andréa Emilia Marques Stinghen2, Rodrigo Bueno de Oliveira3
1Pontifical Catholic University of Paraná.
Abstract:
Chronic kidney disease is characterized by a progressive reduction of glomerular filtration rate and/or the appearance of proteinuria, and subsequently the progressive retention of organic waste compounds called uremic toxins (UT). Over the last decades, a large number of such compounds have been identified and their effects on organs and tissues, especially the cardiovascular system, has been demonstrated. In this review, we present the current classification of UT, as proposed by the EUTox Group, and the effects of some of the probably most important UTs, such as phosphate, FGF-23, PTH, AGEs, indoxyl sulfate and para-cresyl sulfate. We provide an overview on therapeutic approaches aimed to increase their extracorporeal removal via convective and/or adsorptive strategies and to lower their intestinal production/ absorption via dietetic and pharmacological interventions. The recognition that multiple toxins contribute to the uremia supports the need for new therapeutic targets, with a potentially positive impact on CKD progression and survival.
Insights
Uremic toxins (UT) accumulate in chronic kidney disease (CKD), harming organs. This review classifies UT and discusses strategies to remove them and reduce their production, improving CKD patient survival.
Area of Science:
- Nephrology
- Toxicology
- Biochemistry
Background:
- Chronic kidney disease (CKD) involves reduced kidney function and toxin buildup.
- Uremic toxins (UT) negatively impact organs, particularly the cardiovascular system.
- Identifying and managing UT is crucial for CKD patient outcomes.
Purpose of the Study:
- To present the current classification of uremic toxins (UT).
- To review the effects of key UTs like phosphate, FGF-23, PTH, AGEs, indoxyl sulfate, and para-cresyl sulfate.
- To overview therapeutic strategies for UT management in CKD.
Main Methods:
- Literature review on uremic toxin classification and effects.
- Analysis of current therapeutic interventions for UT removal and reduction.
- Synthesis of data on convective, adsorptive, dietary, and pharmacological approaches.
Main Results:
- Uremic toxins are classified by the EUTox Group.
- Key UTs significantly impact CKD pathophysiology and cardiovascular health.
- Therapeutic strategies include extracorporeal removal and reduced intestinal absorption.
Conclusions:
- Multiple toxins contribute to uremic toxicity in CKD.
- Targeting UT offers potential for improved CKD progression and survival.
- New therapeutic targets for UT management are needed.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Acute Kidney Injury III: Clinical Manifestations

